We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+9.62%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$74.2B
AUM Growth
+$3.71B
Cap. Flow
-$2.07B
Cap. Flow %
-2.79%
Top 10 Hldgs %
22.17%
Holding
1,547
New
117
Increased
556
Reduced
728
Closed
120

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$442M
2
BNS icon
Scotiabank
BNS
+$167M
3
KEYS icon
Keysight
KEYS
+$151M
4
TD icon
Toronto Dominion Bank
TD
+$144M
5
VTV icon
Vanguard Morningstar Value ETF
VTV
+$140M

Sector Composition

Rank Sector Weight
1 Financials 23.6%
2 Technology 19.91%
3 Industrials 11.35%
4 Healthcare 9.57%
5 Consumer Discretionary 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILLM
1401
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$49K ﹤0.01%
13,060
-1,030,198
-99% -$4.86M
AKBA icon
1402
Akebia Therapeutics
AKBA
$354M
$48K ﹤0.01%
+21,280
New +$58K
BNGO icon
1403
Bionano Genomics
BNGO
$13M
$46K ﹤0.01%
26
-2
-7% -$5.35K
CSLT
1404
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$44K ﹤0.01%
+28,293
New +$46.7K
UEC icon
1405
Uranium Energy
UEC
$4.92B
$42K ﹤0.01%
12,401
VSTM icon
1406
Verastem
VSTM
$498M
$42K ﹤0.01%
1,702
-45
-3% -$1.42K
DHC
1407
Diversified Healthcare Trust
DHC
$2.16B
$40K ﹤0.01%
12,984
-1,006
-7% -$3.25K
GSAT icon
1408
Globalstar
GSAT
$10.9B
$39K ﹤0.01%
2,216
-156
-7% -$3.42K
SENS icon
1409
Senseonics Holdings Inc
SENS
$274M
$37K ﹤0.01%
688
-536
-44% -$34.8K
HEXO
1410
DELISTED
HEXO Corp. Common Shares
HEXO
$34K ﹤0.01%
3,521
+1,888
+116% +$35.1K
IDEX
1411
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$27K ﹤0.01%
179
-13
-7% -$2.77K
DFTX
1412
Definium Therapeutics
DFTX
$5.59B
$26K ﹤0.01%
1,279
+18
+1% +$575
VBIV
1413
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$23K ﹤0.01%
335
-29
-8% -$2.44K
GERN icon
1414
Geron
GERN
$815M
$20K ﹤0.01%
16,451
-1,412
-8% -$2.02K
VTGN icon
1415
VistaGen Therapeutics
VTGN
$10.3M
$20K ﹤0.01%
346
-28
-7% -$1.82K
TOON icon
1416
Kartoon Studios
TOON
$35.1M
$16K ﹤0.01%
1,554
-106
-6% -$1.39K
ASXC
1417
DELISTED
Asensus Surgical, Inc.
ASXC
$14K ﹤0.01%
12,654
-1,058
-8% -$1.64K
TCRT icon
1418
Alaunos Therapeutics
TCRT
$4.69M
$13K ﹤0.01%
77
-5
-6% -$1.1K
DRRX
1419
DELISTED
DURECT Corp
DRRX
$12K ﹤0.01%
1,243
-83
-6% -$917
NMTR
1420
DELISTED
9 Meters Biopharma
NMTR
$12K ﹤0.01%
618
ATHX
1421
DELISTED
Athersys, Inc. Common Stock
ATHX
$10K ﹤0.01%
450
-23
-5% -$660
CARM
1422
DELISTED
Carisma Therapeutics
CARM
$9K ﹤0.01%
539
+37
+7% +$745
TXMD icon
1423
TherapeuticsMD
TXMD
$23.8M
$8K ﹤0.01%
424
IBIO icon
1424
iBio
IBIO
$70.5M
$7K ﹤0.01%
24
-1
-4% -$381
TNXP icon
1425
Tonix Pharmaceuticals
TNXP
$165M
0

Similar funds

Mackenzie Financial's Q4 2021 Portfolio in Review

As of Q4 2021, Mackenzie Financial held 1,547 positions worth $74.2B, up 5.3% from $70.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mackenzie Financial's Q4 2021 filing shows 117 new, 556 increased, 728 reduced and 120 closed positions. Its largest new stake was Wyndham Hotels & Resorts: 330,939 shares worth $29.7M. The largest sale was Visa, an estimated $442M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Mackenzie Financial's largest Q4 2021 buy was Wyndham Hotels & Resorts: 330,939 shares worth $29.7M.
  • Mackenzie Financial added most to Automatic Data Processing in Q4 2021, an estimated $323M increase.
  • Mackenzie Financial's biggest Q4 2021 reduction was Visa, cutting an estimated $442M.
  • Mackenzie Financial fully exited MSC Industrial Direct in Q4 2021, selling an estimated $54.2M.
  • Mackenzie Financial's ten largest holdings make up 22% of its $74.2B portfolio in Q4 2021.
  • Mackenzie Financial opened 117 new positions and closed 120 in Q4 2021.
  • Mackenzie Financial's portfolio value rose 5.3% quarter-over-quarter to $74.2B.

Based on Mackenzie Financial's 13F filing for Q4 2021, filed 14 Feb 2022.